中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor

文献类型:期刊论文

作者Wang, Xiaowen1,2; Su, Mingbo3,6; Li, You2,4; Liu, Tongchao2,5; Wang, Yujie3,6; Chen, Yabing2; Tang, Le2; He, Yu-Peng1; Ding, Xiaoguang1; Yu, Fang1
刊名BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
出版日期2019-03-15
卷号29期号:6页码:844-847
关键词LSD1 inhibitor Tranylcypromine Menin-MLL1 protei n-protein interaction inhibitor MV4-11 antiproliferative activity Structure activity relationship
ISSN号0960-894X
DOI10.1016/j.bmcl.2019.01.017
通讯作者Yu, Fang(fang.yu@lnpu.edu.cn) ; Zhou, Yubo(ybzhou@simm.ac.cn) ; Chen, Yue-Lei(chenyuelei@gmail.com) ; Xiong, Bing(bxiong@simm.ac.cn)
英文摘要Tranylcypromine moiety extracted from LSD1 inhibitors and 6-trifluoroethyl thienopyrimidine moiety from menin-MLL1 PPI inhibitors were merged to give new chemotypes for medicinal chemistry study. Among 15 new compounds prepared in this work, some exhibited nanomolar LSD1 activity and good selectivity over MAO-A/B, low micromolar menin-MLL1 PPI inhibitory activity, as well as submicromolar MV4-11 antiprofilative activities. Intracellular LSD1 engagement of compounds with higher enzymatic and antiproliferative activities was confirmed by CD86 mRNA up-regulation experiments.
WOS关键词DEMETHYLASE ; DESIGN ; POTENT
资助项目National Natural Science Foundation of China[21877121] ; National Natural Science Foundation of China[81673309] ; National Natural Science Foundation of China[81330076] ; National Natural Science Foundation of China[81703544] ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China[2014ZX09507-002] ; Foundation of Liaoning Science and Technology Agency[20180550899]
WOS研究方向Pharmacology & Pharmacy ; Chemistry
语种英语
WOS记录号WOS:000458623500016
出版者PERGAMON-ELSEVIER SCIENCE LTD
源URL[http://119.78.100.183/handle/2S10ELR8/290521]  
专题新药研究国家重点实验室
通讯作者Yu, Fang; Zhou, Yubo; Chen, Yue-Lei; Xiong, Bing
作者单位1.Liaoning Shihua Univ, Coll Chem Chem Engn & Environm Engn, Dandong Lu West 1, Fushun 113001, Peoples R China
2.Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China
3.Natl Ctr Drug Screening, 189 Guoshoujing Rd, Shanghai 201203, Peoples R China
4.China Pharmaceut Univ, Sch Pharm, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China
5.Shenyang Pharmaceut Univ, Key Lab Struct Based Drug Design & Discovery, Minist Educ, 103 Wenhua Lu, Shenyang 110016, Liaoning, Peoples R China
6.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China
推荐引用方式
GB/T 7714
Wang, Xiaowen,Su, Mingbo,Li, You,et al. Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2019,29(6):844-847.
APA Wang, Xiaowen.,Su, Mingbo.,Li, You.,Liu, Tongchao.,Wang, Yujie.,...&Xiong, Bing.(2019).Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,29(6),844-847.
MLA Wang, Xiaowen,et al."Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 29.6(2019):844-847.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。